Details of the Drug

General Information of Drug (ID: DMJWVCU)

Drug Name

ZYC101a

Indication

Disease Entry	ICD 11	Status	REF
Cervical cancer	2C77.0	Phase 2/3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00264732) A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix. U.S. National Institutes of Health.